Effectiveness of BA.1- and BA.4/BA. 5-Containing Bivalent COVID-19 mRNA Vaccines Against Symptomatic SARS-CoV-2 Infection During the BA.5-Dominant Period in Japan.
Open Forum Infect Dis
; 10(6): ofad240, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37351451
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Clinical_trials
/
Diagnostic_studies
/
Observational_studies
Language:
En
Journal:
Open Forum Infect Dis
Year:
2023
Document type:
Article
Affiliation country:
Country of publication: